AFP and hepatocellular carcinoma: AFP at 1 month post-LRT in combination with miR-21FC had shown significant AUROC differentiating CR vs. PD for all HCC patient (AUC, 0.679; 95% CI, 0.515–0.843, Figure 4Cii) and only AFP secreting HCC patient (AUC, 0.714; 95% CI, 0.523–0.906, Figure 4Cii).